Tiankang (301263.SZ): CKBA Cream Rose Acne Indications Declaration New Drug Clinical Trials Accepted

Zhitong Finance APP News, Taiencang (301263.SZ) announced that its holding subsidiary Jiangsu Bochuangyuan Biomedical Technology Co., Ltd. (referred to as "Bochuangyuan") recently received a acceptance notice issued by the National Medical Products Administration, agreeing to accept Bochuangyuan's application for Phase II/III seamless adaptive clinical trials of CKBA cream for acne.